A recent study demonstrated that opsin 5 (Opn5)-expressing retinal cells (especially retinal ganglion cells) are needed for the refractive development pathway12, which suggests that targeting the OPN5 pathway could be a potential therapeutic molecular target for the future treatment of myopia. The gene discussed is OPN5; the disease is myopia.